These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8518857)

  • 1. Serum and urinary zinc levels in urolithiasis.
    Rangnekar GV; Gaur MS
    Br J Urol; 1993 May; 71(5):527-9. PubMed ID: 8518857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc, copper and oxalocalcic urolithiasis.
    Grases F; Ruiz J; Costa-Bauzá A; Coll R; Conte A
    Urol Int; 1993; 50(4):205-8. PubMed ID: 8506591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of urinary zinc and copper on calcium oxalate stone formation.
    Ozgurtas T; Yakut G; Gulec M; Serdar M; Kutluay T
    Urol Int; 2004; 72(3):233-6. PubMed ID: 15084769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxalate urolithiasis: significance of serum and urinary oxalate.
    Butz M; Kohlbecker G
    Urol Int; 1980; 35(4):303-8. PubMed ID: 7394936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.
    Anan G; Yoneyama T; Noro D; Tobisawa Y; Hatakeyama S; Sutoh Yoneyama M; Yamamoto H; Imai A; Iwamura H; Kohada Y; Mikami J; Ito J; Kaiho Y; Yoneyama T; Hashimoto Y; Sato M; Ohyama C
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc, copper and manganese in serum, urine and stones.
    Komleh K; Hada P; Pendse AK; Singh PP
    Int Urol Nephrol; 1990; 22(2):113-8. PubMed ID: 2354889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients.
    Atakan IH; Kaplan M; Seren G; Aktoz T; Gül H; Inci O
    Int Urol Nephrol; 2007; 39(2):351-6. PubMed ID: 17203355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of standard diet in urolithiasis.
    Bastian HP; Vahlensieck W
    Eur Urol; 1975; 1(5):235-7. PubMed ID: 1233189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary zinc excretion in patients with urolithiasis.
    Revúsová V; Zvara V; Gratzlová J
    Urol Int; 1973; 28(2):72-9. PubMed ID: 4703931
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of urinary excretion of magnesium in patients with urolithiasis with special respect to recurrence rate of stone formation (author's transl)].
    Zechner O; Latal D
    Urologe A; 1978 Jul; 17(4):258-60. PubMed ID: 684999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma.
    Schmiedl A; Schwille PO
    Magnes Res; 2003 Sep; 16(3):192-205. PubMed ID: 14596324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of urinary stone formation in 40 recurrent stone formers.
    François B; Cahen R; Pascal B
    Br J Urol; 1986 Oct; 58(5):479-83. PubMed ID: 3779347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of renal cyclic adenosine monophosphate, serum parathyroid hormone and phosphate reabsorption in recurrent calcium urolithiasis, healthy controls and hyperparathyroidism (author's transl)].
    Schwille PO; Bornhof C; Thun R; Scholz D; Bötticher R; Schellerer W; Sigel A
    Klin Wochenschr; 1978 Jun; 56(12):601-6. PubMed ID: 210311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors determining active urinary stone formation in patients with urolithiasis.
    Netelenbos JC; Zwijnenburg PJ; ter Wee PM
    Clin Nephrol; 2005 Mar; 63(3):188-92. PubMed ID: 15786819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
    Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
    J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urinary uric acid levels in healthy subjects and in patients with urolithiasis.
    Sila-On A; Pavaro U; Nuchpramool W
    J Med Assoc Thai; 1991 Aug; 74(8):352-7. PubMed ID: 1791385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of zinc in urinary stone disease.
    Negri AL
    Int Urol Nephrol; 2018 May; 50(5):879-883. PubMed ID: 29344880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
    Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
    Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal and metabolic disorders as systemic factor for the formation of urinary calculi].
    Aliaev IuG; Egshatian LV; Rapoport LM; Lartsova EV
    Urologiia; 2014; (5):35-9. PubMed ID: 25807757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is hypocitraturia associated with phosphaturia--a potential cause of calcium urolithiasis in first-time stone formers.
    Khand FD; Ansari AF; Khand TU; Memon JM
    J Pak Med Assoc; 1994 Aug; 44(8):179-81. PubMed ID: 7996662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.